Show Notes
Please click below to fill out the survey for this episode: Science Fare Podcast Feedback Form
Our guest today is Stephen Steiner. Stephen is President, CEO, and founder of Aerogel Technologies, a company based outside of Boston. Stephen has a PhD from the Massachusetts Institute of Technology in Materials Chemistry and Engineering which he completed in the Department of Aeronautics and Astronautics, and a Master’s Degree in Materials Science and Engineering, also from MIT. And prior to graduate school, Stephen got his Bachelor’s degree in Chemistry at the University of Wisconsin in Madison, and that is actually how I know Stephen! I was in the graduate program in chemistry and a lab teaching assistant one summer — I think it was the summer of 2001 — and Stephen was working at the stockroom window where undergrads needed to get various supplies for completing their lab projects.
Stephen has such an interesting story of really falling in love with science at a young age and doing so many interesting things on both the discovery side and the business side of science, focused on aerogels.
In this MINI episode, Stephen talks to us about the invention of aerogels, and how the process of making them defies the ideal gas law, PV = nRT, and how we see that by the formation of a critical fluid. Tune in on Thursday for the full-length interview!
Highlights of the episode:
*Susan introduces Stephen and today’s topic [0:56]; *Stephen tells us what aerogels are [3:02]; *Stephen describes the invention of aerogels [3:38]; *Stephen talks about why the ideal gas law no longer holds in the formation of aerogels [6:26].
Hosted on Acast. See acast.com/privacy for more information.
More from Science Fare
In this mini episode, Dr. Jonathan Bogan explains how insulin triggers the TUG protein to help move GLUT 4 transporter proteins from inside the cell to the cell membrane. There, they transport glucose from the bloodstream into the cell using facilitated diffusion. Tune in next week for the full-length interview. Hosted on Acast. See acast.com/privacy for more information.
Dr. Dina Simkin is an Research Assistant Professor at Northwestern University's Feinberg School of Medicine whose research mainly focuses on how on how mutations in ion channel proteins contribute to pediatric epilepsy and neurodevelopmental disorders. Dr. Simkin earned her BS in Biochemistry, and then proceeded to earn PhDs in Neuroscience, Biophysics, and in Cellular and Molecular Pharmacology. She additionally completed post-graduate training in both the neurophysiology of aging and stem cell-derived neuronal models of epileptic channelopathy.
In this mini episode, Dr. Dina Simkin tells us how she uses CRISPR to do more elegant experiments for her work on ion channels. Tune in next week for the full-length interview. Hosted on Acast. See acast.com/privacy for more information.
Lydia Pecker, M.D., is a pediatric hematologist and director of research and advocacy at the Sickle Cell Center for Adults at Johns Hopkins University. She previously served as the founding director of the Center's Young Adult Clinic, which was built to support young people transitioning from pediatric to adult care systems. She received her undergraduate degree in Africana studies from Brown University, earned her M.D. at the University of Pennsylvania School of Medicine, and received a Master's degree in Health Sciences from the Bloomberg School of Public Health.
In this mini episode, Dr. Lydia Pecker explains the complexity in real-life sickle cell inheritance patterns. Tune in next week for the full-length interview. Hosted on Acast. See acast.com/privacy for more information.